Skip to content

house · Committee report

H. Rept. 118-765,Part 2

PROVIDERS AND PAYERS COMPETE ACT

2024-11-22

Committees

Associated legislation

Text

Dissenting Views

[To accompany H.R. 3284] The Committee on Ways and Means, to whom was referred the bill (H.R. 3284) to require the Secretary of Health and Human Services to submit an annual report on the impact of certain Medicare regulations on provider and payer consolidation, having considered the same, reports favorably thereon with an amendment and recommends that the bill as amended do pass. CONTENTS Page I. SUMMARY AND BACKGROUND...........................................3 A. Purpose and Summary................................. 3 B. Background and Need for Legislation................. 3 C. Legislative History................................. 3 D. Legislative History................................. 3 II. EXPLANATION OF THE BILL..........................................4 A. Ensuring HHS Considers the Potential Impacts of Medicare Regulations and Payments Have on Consolidation and Competition...................... 4 III. VOTE OF THE COMMITTEE............................................4 IV. BUDGET EFFECTS OF THE BILL.......................................5 A. Committee Estimate of Budgetary Effects............. 5 B. Statement Regarding New Budget Authority and Tax Expenditures Budget Authority...................... 5 V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE HOUSE.......5 A. Committee Oversight Findings and Recommendations.... 5 B. Statement of General Performance Goals and Objectives......................................... 5 C. Information Relating to Unfunded Mandates........... 6 D. Congressional Earmarks, Limited Tax Benefits, and Limited Tariff Benefits............................ 6 E. Duplication of Federal Programs..................... 6 VI. CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED............6 Changes in Existing Law Proposed by the Bill, as Reported........................................... 6 VII. DISSENTING VIEWS................................................15 The amendment is as follows: Strike all after the enacting clause and insert the following: SECTION 1. SHORT TITLE. This Act may be cited as the ``Providers and Payers COMPETE Act''. SEC. 2. ANNUAL REPORT ON THE IMPACT OF CERTAIN MEDICARE REGULATIONS ON PROVIDER AND PAYER CONSOLIDATION; PUBLIC COMMENT ON PROVIDER AND PAYER CONSOLIDATION FOR CERTAIN PROPOSED RULES. (a) Annual Report.--Not later than December 31, 2026, and annually thereafter, the Secretary of Health and Human Services (in this section referred to as the ``Secretary'') shall submit to Congress a report on the impact in the aggregate on provider and payer consolidation with respect to regulations and rules for parts A, B, C, and D of title XVIII of the Social Security Act (42 U.S.C. 1395c et seq.) implemented in the calendar year immediately prior to such report. Such report shall include regulations and rules that-- (1) implement a change to an applicable payment system, a rate schedule, or another payment system under parts A, B, C, or D of such title; or (2) result in a significant rule effecting provider or payer consolidation. (b) Public Comment on Impact to Provider and Payer Consolidation.-- Beginning for 2025, as part of any notice and comment rulemaking process that could result in a significant rule affecting provider or payer consolidation with respect to a proposed rule for parts A, B, C, and D of title XVIII of the Social Security Act (42 U.S.C. 1395c et seq.), the Secretary shall seek public comment on the potential impact of such proposed rule on provider and payer consolidation in the aggregate. (c) Definitions.--In this section: (1) Provider and payer consolidation.--The term ``provider and payer consolidation'' includes the vertical or horizontal integration among providers of services (as defined in subsection (u) of section 1861 of the Social Security Act (42 U.S.C. 1395x)), suppliers (as defined in subsection (d) of such section), accountable care organizations under section 1899 of the Social Security Act (42 U.S.C. 1395jjj), Medicare Advantage organizations, PDP sponsors, pharmacy benefit managers, pharmacies, and integrated delivery systems. (2) Applicable payment system.--The term ``applicable payment system'' includes-- (A) with respect to outpatient hospital services, the prospective payment system for covered OPD services established under section 1833(t) of such Act (42 U.S.C. 1395(l)); and (B) with respect to physicians' services, the physician fee schedules established under section 1848 of such Act (42 U.S.C. 1395w-4). SEC. 3. CONSIDERATION OF EFFECTS ON PROVIDER AND PAYER CONSOLIDATION WITH RESPECT TO CMI MODELS. (a) In General.--Section 1115A(b)(4)(A) of the Social Security Act (42 U.S.C. 1315a(b)(4)(A)) is amended-- (1) in clause (i), by striking at the end ``and''; (2) in clause (ii), by striking the period at the end and inserting ``; and''; and (3) by adding at the end the following new clause: ``(iii) the extent to which, and how, the model has affected and could affect provider and payer consolidation, which includes the vertical or horizontal integration among providers of services (as defined in subsection (u) of section 1861), suppliers (as defined in subsection (d) of such section), and accountable care organizations under section 1899, or pursuant to models under this section.''. (b) Effective Date.--The amendments made by subsection (a) shall apply with respect to models tested on or after January 1, 2025. I. SUMMARY AND BACKGROUND A. Purpose and Summary The bill, H.R. 3284, the ``Providers and Payers COMPETE Act,'' as ordered reported by the Committee on Ways and Means on July 26, 2023, to require the Secretary of Health and Human Services to submit an annual report on the impact of certain Medicare regulations on provider and payer consolidation. B. Background and Need for Legislation On May 15, 2023, Representative Burgess (R-TX), Representative Dingell (D-MI), Representative Ferguson (R-GA), and Representative Bilirakis (R-FL) introduced H.R. 3284, legislation to ensure HHS is considering the impact of certain regulations and payment models on health care consolidation. The Committee on Ways and Means received an additional referral for the bill because it includes Medicare provisions that fall within the jurisdiction of the Committee, including changes to relevant provisions of the Social Security Act. As the Committee explores the impact health care payer and provider consolidation has on patients and taxpayers, it is the Committee's priority to protect and strengthen competition in the health care market. This resulted in the Committee considering the role the Centers for Medicare and Medicaid Services (CMS) and the Center for Medicare and Medicaid Innovation (CMMI) may have impacting health care consolidation. C. Legislative History

Background

H.R. 3284 was introduced on May 15, 2023, and was referred to the Committee on Energy and Commerce and the Committee on Ways and Means. Committee Hearings On Wednesday, May 17, the Committee held a Health Sub- Committee Hearing, ``Why Health Care is Unaffordable: Anticompetitive and Consolidated Markets.''

Committee Action

The Committee on Ways and Means marked up H.R. 3284, the ``Providers and Payers COMPETE Act,'' on July 26, 2023, and ordered the bill, as amended, favorably reported (with a quorum being present). D. Legislative History Pursuant to clause 3(c)(6) of rule XIII, the following hearings were used to develop and consider H.R. 3284: Committee on Ways and Means Health Sub-Committee Hearing, ``Why Health Care is Unaffordable: Anticompetitive and Consolidated Markets.'' II. EXPLANATION OF THE BILL A. Ensuring HHS Considers the Potential Impacts of Medicare Regulations and Payments Have on Consolidation and Competition PRESENT LAW Section 553 of U.S. Code sets standards for the Administration's rule making procedures. Section 1315a(b)(4)(A) of the Social Security Act instructs the Secretary to evaluate CMMI models based on two factors, the quality of care furnished under the model and the changes in spending generated by the model. REASONS FOR CHANGE The Committee observes that consolidation in the health care marketplace has frequently resulted in increased costs and worse outcomes for patients. The Committee observes that despite being the single largest health care payer and responsible for regulating nearly all health care facilities and providers, CMS does not seek comment on how their payment models and regulatory changes may impact competition and consolidation in the health care marketplace. This policy ensures the effects such models may have on payer and provider consolidation is considered by CMS and CMMI. The Committee also notes that providing this information in an annual report submitted to Congress will further inform Congress on the impacts Medicare rules have on health care consolidation and may serve as a resource for potential legislative considerations. EXPLANATION OF PROVISION This provision requires HHS to annually submit a report to Congress on the potential aggregate impact of payment rules and regulations for Medicare Parts A, B, C, and D from the previous year. Additionally, CMS is required to seek public comment on potential impacts of proposed rules on provider and payer consolidation as part of the notice and comment rulemaking process. Additionally, CMMI is also required to consider how payment models impact provider and payer consolidation as part of their model evaluation. EFFECTIVE DATE The provision applies to CMS rulemaking and CMMI models beginning on January 1, 2025. III. VOTE OF THE COMMITTEE Pursuant to clause 3(b) of rule XIII of the Rules of the House of Representatives, the following statement is made concerning the vote of the Committee on Ways and Means in its consideration of H.R. 3284, the ``Providers and Payers COMPETE Act'' on July 26, 2023. H.R. 3284 was ordered favorably reported to the House of Representatives as amended by a roll call vote of 23 yeas to 17 nays (with a quorum being present). The vote was as follows: ---------------------------------------------------------------------------------------------------------------- Representative Yea Nay Present Representative Yea Nay Present ---------------------------------------------------------------------------------------------------------------- Mr. Smith (MO)..................... X ...... ......... Mr. Neal............. ...... X ......... Mr. Buchanan....................... X ...... ......... Mr. Doggett.......... ...... X ......... Mr. Smith (NE)..................... X ...... ......... Mr. Thompson......... ...... X ......... Mr. Kelly.......................... X ...... ......... Mr. Larson........... ...... X ......... Mr. Schweikert..................... X ...... ......... Mr. Blumenauer....... ...... X ......... Mr. LaHood......................... X ...... ......... Mr. Pascrell......... ...... X ......... Dr. Wenstrup....................... X ...... ......... Mr. Davis............ ...... X ......... Mr. Arrington...................... ...... ...... ......... Ms. Sanchez.......... ...... X ......... Dr. Ferguson....................... X ...... ......... Mr. Higgins.......... ...... X ......... Mr. Estes.......................... X ...... ......... Ms. Sewell........... ...... ...... ......... Mr. Smucker........................ X ...... ......... Ms. DelBene.......... ...... X ......... Mr. Hern........................... X ...... ......... Ms. Chu.............. ...... X ......... Ms. Miller......................... X ...... ......... Ms. Moore............ ...... X ......... Dr. Murphy......................... X ...... ......... Mr. Kildee........... ...... X ......... Mr. Kustoff........................ X ...... ......... Mr. Beyer............ ...... X ......... Mr. Fitzpatrick.................... X ...... ......... Mr. Evans............ ...... X ......... Mr. Steube......................... X ...... ......... Mr. Schneider........ ...... X ......... Ms. Tenney......................... X ...... ......... Mr. Panetta.......... ...... X ......... Mrs. Fischbach..................... ...... ...... ......... Mr. Moore.......................... X ...... ......... Mrs. Steel......................... X ...... ......... Ms. Van Duyne...................... X ...... ......... Mr. Feenstra....................... X ...... ......... Ms. Malliotakis.................... X ...... ......... Mr. Carey.......................... X ...... ......... ---------------------------------------------------------------------------------------------------------------- IV. BUDGET EFFECTS OF THE BILL A. Committee Estimate of Budgetary Effects In compliance with clause 3(d) of rule XIII of the Rules of the House of Representatives, a cost estimate provided by the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974 was not made available to the Committee in time for the filing of this report. The Chairman of the Committee shall cause such estimate to be printed in the Congressional Record upon its receipt by the Committee. B. Statement Regarding New Budget Authority and Tax Expenditures Budget Authority In compliance with clause 3(c)(2) of rule XIII of the Rules of the House of Representatives, the Committee states that the bill involves no new or increased budget authority. V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE HOUSE A. Committee Oversight Findings and Recommendations With respect to clause 3(c)(1) of rule XIII of the Rules of the House of Representatives, the Committee made findings and recommendations that are reflected in this report. B. Statement of General Performance Goals and Objectives With respect to clause 3(c)(4) of rule XIII of the Rules of the House of Representatives, the Committee advises that the bill does not authorize funding, so no statement of general performance goals and objectives is required. C. Information Relating to Unfunded Mandates This information is provided in accordance with section 423 of the Unfunded Mandates Reform Act of 1995 (Pub. L. No. 104- 4). The Committee has determined that the bill does not contain Federal mandates on the private sector. The Committee has determined that the bill does not impose a Federal intergovernmental mandate on State, local, or tribal governments. D. Congressional Earmarks, Limited Tax Benefits, and Limited Tariff Benefits With respect to clause 9 of rule XXI of the Rules of the House of Representatives, the Committee has carefully reviewed the provisions of the bill, and states that the provisions of the bill do not contain any congressional earmarks, limited tax benefits, or limited tariff benefits within the meaning of the rule. E. Duplication of Federal Programs In compliance with clause 3(c)(5) of rule XIII of the Rules of the House of Representatives, the Committee states that no provision of the bill establishes or reauthorizes: (1) a program of the Federal Government known to be duplicative of another Federal program; (2) a program included in any report from the Government Accountability Office to Congress pursuant to section 21 of Public Law 111-139; or (3) a program related to a program identified in the most recent Catalog of Federal Domestic Assistance, published pursuant to the Federal Program Information Act (Pub. L. No. 95-220, as amended by Pub. L. No. 98-169). VI. CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED Changes in Existing Law Proposed by the Bill, as Reported Changes in Existing Law Made by the Bill, as Reported In compliance with clause 3(e) of rule XIII of the Rules of the House of Representatives, changes in existing law made by the bill, as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italics, and existing law in which no change is proposed is shown in roman): SOCIAL SECURITY ACT * * * * * * * TITLE XI--GENERAL PROVISIONS, PEER REVIEW, AND ADMINISTRATIVE SIMPLIFICATION * * * * * * * Part A--General Provisions * * * * * * * center for medicare and medicaid innovation Sec. 1115A. (a) Center for Medicare and Medicaid Innovation Established.-- (1) In general.--There is created within the Centers for Medicare & Medicaid Services a Center for Medicare and Medicaid Innovation (in this section referred to as the ``CMI'') to carry out the duties described in this section. The purpose of the CMI is to test innovative payment and service delivery models to reduce program expenditures under the applicable titles while preserving or enhancing the quality of care furnished to individuals under such titles. In selecting such models, the Secretary shall give preference to models that also improve the coordination, quality, and efficiency of health care services furnished to applicable individuals defined in paragraph (4)(A). (2) Deadline.--The Secretary shall ensure that the CMI is carrying out the duties described in this section by not later than January 1, 2011. (3) Consultation.--In carrying out the duties under this section, the CMI shall consult representatives of relevant Federal agencies, and clinical and analytical experts with expertise in medicine and health care management. The CMI shall use open door forums or other mechanisms to seek input from interested parties. (4) Definitions.--In this section: (A) Applicable individual.--The term ``applicable individual'' means-- (i) an individual who is entitled to, or enrolled for, benefits under part A of title XVIII or enrolled for benefits under part B of such title; (ii) an individual who is eligible for medical assistance under title XIX, under a State plan or waiver; or (iii) an individual who meets the criteria of both clauses (i) and (ii). (B) Applicable title.--The term ``applicable title'' means title XVIII, title XIX, or both. (5) Testing within certain geographic areas.--For purposes of testing payment and service delivery models under this section, the Secretary may elect to limit testing of a model to certain geographic areas. (b) Testing of Models (Phase I).-- (1) In general.--The CMI shall test payment and service delivery models in accordance with selection criteria under paragraph (2) to determine the effect of applying such models under the applicable title (as defined in subsection (a)(4)(B)) on program expenditures under such titles and the quality of care received by individuals receiving benefits under such title. (2) Selection of models to be tested.-- (A) In general.--The Secretary shall select models to be tested from models where the Secretary determines that there is evidence that the model addresses a defined population for which there are deficits in care leading to poor clinical outcomes or potentially avoidable expenditures. The Secretary shall focus on models expected to reduce program costs under the applicable title while preserving or enhancing the quality of care received by individuals receiving benefits under such title. The models selected under this subparagraph may include, but are not limited to, the models described in subparagraph (B). (B) Opportunities.--The models described in this subparagraph are the following models: (i) Promoting broad payment and practice reform in primary care, including patient-centered medical home models for high-need applicable individuals, medical homes that address women's unique health care needs, and models that transition primary care practices away from fee-for-service based reimbursement and toward comprehensive payment or salary-based payment. (ii) Contracting directly with groups of providers of services and suppliers to promote innovative care delivery models, such as through risk-based comprehensive payment or salary-based payment. (iii) Utilizing geriatric assessments and comprehensive care plans to coordinate the care (including through interdisciplinary teams) of applicable individuals with multiple chronic conditions and at least one of the following: (I) An inability to perform 2 or more activities of daily living. (II) Cognitive impairment, including dementia. (iv) Promote care coordination between providers of services and suppliers that transition health care providers away from fee-for-service based reimbursement and toward salary- based payment. (v) Supporting care coordination for chronically-ill applicable individuals at high risk of hospitalization through a health information technology-enabled provider network that includes care coordinators, a chronic disease registry, and home tele-health technology. (vi) Varying payment to physicians who order advanced diagnostic imaging services (as defined in section 1834(e)(1)(B)) according to the physician's adherence to appropriateness criteria for the ordering of such services, as determined in consultation with physician specialty groups and other relevant stakeholders. (vii) Utilizing medication therapy management services, such as those described in section 935 of the Public Health Service Act. (viii) Establishing community-based health teams to support small-practice medical homes by assisting the primary care practitioner in chronic care management, including patient self- management, activities. (ix) Assisting applicable individuals in making informed health care choices by paying providers of services and suppliers for using patient decision- support tools, including tools that meet the standards developed and identified under section 936(c)(2)(A) of the Public Health Service Act, that improve applicable individual and caregiver understanding of medical treatment options. (x) Allowing States to test and evaluate fully integrating care for dual eligible individuals in the State, including the management and oversight of all funds under the applicable titles with respect to such individuals. (xi) Allowing States to test and evaluate systems of all-payer payment reform for the medical care of residents of the State, including dual eligible individuals. (xii) Aligning nationally recognized, evidence-based guidelines of cancer care with payment incentives under title XVIII in the areas of treatment planning and follow-up care planning for applicable individuals described in clause (i) or (iii) of subsection (a)(4)(A) with cancer, including the identification of gaps in applicable quality measures. (xiii) Improving post-acute care through continuing care hospitals that offer inpatient rehabilitation, long- term care hospitals, and home heal

Source: https://api.congress.gov/v3/committee-report/118/hrpt/765